vaccines-world-2017-keynote

3 / 7

alliedacademies
Page 11
Virology Research Journal
Volume 1 Issue 4
Notes:
Vaccines World 2017
November 09-10, 2017 Vienna, Austria
21st World Congress and Exhibition on
VACCINES, VACCINATION & IMMUNIZATION
Dereuddre Bosquet N et. al. (2017) Attenuated and vectored vaccines protect non-human primates against
Chikungunya virus. J. Clin. Invest. Insight 2(6):e83527.
• Olafsdottir TA, Lindqvist M, Nookaew I, Andersen PL, Maertzdorf J, Persson J, (2016) Comparative systems
analyses reveal molecular signatures of clinically tested vaccine adjuvants. Nature Scientific Reports. 6:39097.
• Knudsen NPH, Olsen A, Buonsanti C, Follmann F, Zhang Y et. al. (2016) Different human vaccine adjuvants
promote distinct antigen-independent immunological signatures tailored to different pathogens. Nature Scientific
Reports 6:19570.
• Comstedt P, Hanner M, Schüler W, Meinke A, Schlegl R and Lundberg U (2015) Characterization and
Optimization of a Novel Vaccine for Protection against Lyme Borreliosis. Vaccine 44:5982-88.
Biography
Andreas Meinke is an expert in Micro- & molecular biology and infectious disease, with more than 18 years of experience in vaccine R&D. He graduated in Biology,
performed his PhD work at the University of British Columbia in Vancouver, Canada and lectured at the University Vienna as an Assistant Professor. At Valneva he was
instrumental for the development of the AIP technology and for the development of several vaccine candidates towards clinical testing. During his career, he has authored
and co-authored more than 70 publications and filed more than 20 patents in the field of antigen discovery and vaccine research.